TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30321268

Group type: EXPERIMENTAL
Intervention: Fact Box decision support tools on antibiotics for pneumonia and artificial hydration in advanced dementia (at 1‐month)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 232
Study: 28889759

Group type: EXPERIMENTAL
Intervention: Nintedanib with add-on pirfenidone (titrated to 801 mg three times daily)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Nintedanib alone (150 mg twice daily)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Nintedanib with add-on pirfenidone
Number of subjects: 104

Group type: COMPARATOR
Intervention: Nintedanib alone
Number of subjects: 104
Study: 26646758

Group type: EXPERIMENTAL
Intervention: Immediate print-out LoMoS (intervention)
Number of subjects: 264

Group type: COMPARATOR
Intervention: No immediate print-out LoMoS (control)
Number of subjects: 264
Study: 24628488

Group type: EXPERIMENTAL
Intervention: MTV's 16 and Pregnant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22109997

Group type: EXPERIMENTAL
Intervention: Oral rapamycin plus bare-metal stent (OR + BMS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 200
Study: 19395185

Group type: EXPERIMENTAL
Intervention: Radiation Therapy (RT) 10 Gy
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Radiation Therapy (RT) 20 Gy
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Chemotherapy with doxorubicin (three drugs)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Chemotherapy with dactinomycin and vincristine (two drugs)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Spillage present (Stage II patients)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Spillage absent (Stage II patients)
Number of subjects: 450
Study: 17697416

Group type: EXPERIMENTAL
Intervention: Training by experienced therapists (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Training by trained laypersons (n=10)
Number of subjects: 20
Study: 16707509

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Surgical management
Number of subjects: 1200
Study: 15275766

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 63

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 63
Study: 10625790

Group type: EXPERIMENTAL
Intervention: Tannenbaum (TB) stent (10F, 7 cm long)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Cotton‐Huibregtse (CH) stent
Number of subjects: 57
Study: 9014648

Group type: EXPERIMENTAL
Intervention: Reduced-fat products
Number of subjects: 37

Group type: COMPARATOR
Intervention: Full-fat equivalents
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Higher activity level subjects
Number of subjects: 37
Study: 1396651

Group type: EXPERIMENTAL
Intervention: Stimulation frequency of 50 Hz
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stimulation frequency of 100 Hz
Number of subjects: 10
Study: 3891710

Group type: EXPERIMENTAL
Intervention: amoxycillin 250 mg three times a day for seven days
Number of subjects: 37

Group type: COMPARATOR
Intervention: trimethoprim 200 mg twice a day for seven days
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: amoxycillin
Number of subjects: 37
Study: 31702949

Group type: EXPERIMENTAL
Intervention: Online wellness intervention
Number of subjects: 382
Study: 30861997

Group type: COMPARATOR
Intervention: Low-fat/high-protein diet (n = 132)
Number of subjects: 132

Group type: COMPARATOR
Intervention: High-fat/high-protein diet (n = 35)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Dietary fiber intake ≥35 g (n = 15)
Number of subjects: 132
Study: 28369055

Group type: EXPERIMENTAL
Intervention: Feedback via smartwatch
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 40
Study: 25638438

Group type: EXPERIMENTAL
Intervention: Bibliotherapy intervention (reading Uncle Lightfoot, Flip that Switch: Overcoming Fear of the Dark, Academic Version) over 4 weeks
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Bibliotherapy intervention
Number of subjects: 9

Group type: COMPARATOR
Intervention: Baseline control conditions (1, 2, or 3 weeks)
Number of subjects: 9
Study: 23472104

Group type: EXPERIMENTAL
Intervention: Step pad training (intervention group) - computerized step pad system connected to TVs, recommended 2-3 sessions per week for 15-20 minutes each for eight weeks.
Number of subjects: 37
Study: 21732100

Group type: EXPERIMENTAL
Intervention: Vaginal surgery
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Abdominal surgery
Number of subjects: 94
Study: 18267042

Group type: EXPERIMENTAL
Intervention: A single dose of sulphadoxine/pyrimethamine (25 mg/kg of sulphadoxine/1.25 mg/kg of pyrimethamine)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Amodiaquine (10 mg/kg/day x 3 days)
Number of subjects: 140
Study: 16909403

Group type: EXPERIMENTAL
Intervention: 2D ultrasonography followed by 3D/4D ultrasonography
Number of subjects: 124

Group type: COMPARATOR
Intervention: 2D ultrasonography alone
Number of subjects: 124
Study: 16285277

Group type: EXPERIMENTAL
Intervention: Ondansetron (8‐12 mg orally per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study: 10900738

Group type: EXPERIMENTAL
Intervention: Double gloving
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Reinforced gowns
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal gowns
Number of subjects: 80
Study: 8824473

Group type: EXPERIMENTAL
Intervention: Microemulsion formulation of cyclosporine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional formulation of cyclosporine
Number of subjects: 21
Study: 1575336

Group type: EXPERIMENTAL
Intervention: Low-dose propofol (0.08 mg/kg loading dose and 0.5 mg.kg‐1.h‐1 infusion)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderate-dose propofol (0.16 mg/kg loading dose and 1.0 mg.kg‐1.h‐1 infusion)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-dose propofol (0.32 mg/kg loading dose and 2.0 mg.kg‐1.h‐1 infusion)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (Intralipid)
Number of subjects: 10
Study: 3914701

Group type: EXPERIMENTAL
Intervention: Piroxicam at 20 mg per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ibuprofen at 2,400 mg per day
Number of subjects: 20
Study: 31829138

Group type: EXPERIMENTAL
Intervention: Induction of labor (vaginal dinoprostone or amniotomy or oxytocin as appropriate)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Expectant management (await labor for at least 24 h unless indicated intervention)
Number of subjects: 318
Study: 30368450

Group type: EXPERIMENTAL
Intervention: ToyBox-Scotland intervention (adapted ToyBox intervention)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ToyBox-Scotland intervention
Number of subjects: 6
Study: 26978587

Group type: EXPERIMENTAL
Intervention: real‐rTMS
Number of subjects: 20

Group type: COMPARATOR
Intervention: sham‐rTMS
Number of subjects: 20
Study: 24146070

Group type: EXPERIMENTAL
Intervention: Covariate adjustment for country and socio-demographic variables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceptions of physical and mental health
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIV risk behavior variables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD4 count
Number of subjects: 0
Study: 22683131

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 515

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 515
Study: 20633037

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 100 mg/day starting on day 1
Number of subjects: 261

Group type: COMPARATOR
Intervention: Phenytoin (PHT) 1,000 mg on day 1 followed by 300 mg/day maintenance
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 261
Study: 17127586

Group type: EXPERIMENTAL
Intervention: Protein supplement (2 g x kg(‐1) body mass x day(‐1))
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Whole-body low-magnitude (3.5 g), low-frequency (30 Hz) mechanical vibration (WBV) for 10 min each day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Protein supplement (2 g x kg(‐1) body mass x day(‐1)) + WBV
Number of subjects: 10

Group type: COMPARATOR
Intervention: Whole-body vibration (WBV) alone
Number of subjects: 10
Study: 15467036

Group type: EXPERIMENTAL
Intervention: Highly dense breasts (i.e., > or =75% of the breast occupied by dense tissue)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Less than 25% of the breast occupied by dense tissue
Number of subjects: 504
Study: 11712935

Group type: EXPERIMENTAL
Intervention: Early invasive strategy of coronary angiography between 4 and 48 hours after randomization and revascularization when feasible (n = 1114)
Number of subjects: 2220

Group type: COMPARATOR
Intervention: Conservative strategy of medical treatment and predischarge exercise tolerance testing (n = 1106)
Number of subjects: 2220

Group type: EXPERIMENTAL
Intervention: Early invasive strategy for patients with cTnI levels of 0.1 ng/mL or more (n = 1087)
Number of subjects: 2220

Group type: COMPARATOR
Intervention: Conservative strategy for patients with cTnI levels of less than 0.1 ng/mL
Number of subjects: 2220

Group type: EXPERIMENTAL
Intervention: Early invasive strategy for patients with low-level (0.1-0.4 ng/mL) cTnI elevation
Number of subjects: 2220
Study: 9130895

Group type: EXPERIMENTAL
Intervention: GnRH agonist and FSH
Number of subjects: 323

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 323
Study: 8221426

Group type: EXPERIMENTAL
Intervention: Acetaminophen half dose (162.5 mg per capsule, 2 capsules)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Acetaminophen full dose (325 mg per capsule, 2 capsules)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo (2 identical capsules)
Number of subjects: 262
Study: 3310451

Group type: EXPERIMENTAL
Intervention: Immunoglobulin therapy
Number of subjects: 74
Study: 30088226

Group type: EXPERIMENTAL
Intervention: Group counseling sessions (6 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 60
Study: 29301558

Group type: EXPERIMENTAL
Intervention: Leucine supplementation
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Perindopril (ACE inhibitor)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo for leucine
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo for perindopril
Number of subjects: 440
Study: 26612089

Group type: EXPERIMENTAL
Intervention: Rejection of novel foods at 6 months of age
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Rejection of novel foods at 12 months of age
Number of subjects: 82
Study: 25143169

Group type: EXPERIMENTAL
Intervention: Dezoxine 0.1 mg×kg(‐1) and dexmedetomidine 0.4 µg×kg(‐1)×h(‐1) until the end of the first ocular muscle correcting
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 60
Study: 21746751

Group type: EXPERIMENTAL
Intervention: Group 1: pre-fixed appointment plus standard leaflet
Number of subjects: 5360

Group type: EXPERIMENTAL
Intervention: Group 2: pre-fixed appointment plus a more comprehensive booklet
Number of subjects: 5360

Group type: EXPERIMENTAL
Intervention: Group 3: point (ii) plus the offer of a counselling session
Number of subjects: 5360

Group type: COMPARATOR
Intervention: Group 4: invitation to contact the centre for information and arrange participation
Number of subjects: 5360
Study: 20656748

Group type: EXPERIMENTAL
Intervention: Isoflurane preconditioning (10-minute exposure to isoflurane 2.5% followed by 5 minutes of washout)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (3 episodes of 1-minute aortic cross-clamping followed by 4 minutes of reperfusion after each episode)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no preconditioning technique)
Number of subjects: 45
Study: 18246841

Group type: EXPERIMENTAL
Intervention: Advance telephone prompt group (157 GDPs)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Control group (158 GDPs)
Number of subjects: 315
Study: 15833570

Group type: EXPERIMENTAL
Intervention: Smoking to control weight (5 lb gain)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking to control weight (10 lb gain)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking to control weight (20 lb gain)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no weight gain)
Number of subjects: 0
Study: 11978336

Group type: EXPERIMENTAL
Intervention: Conventional workup and PET (CWU+PET)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Conventional workup (CWU)
Number of subjects: 188
Study: 10492055

Group type: COMPARATOR
Intervention: Salmeterol dry powder, 50 microg twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Formoterol dry powder, 12 microg twice daily
Number of subjects: 16
Study: 8610621

Group type: EXPERIMENTAL
Intervention: Combination lovastatin and probucol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 2015146

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (with adrenaline) 3 mg/kg body weight (Group A)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 0.5% plain bupivacaine 3 mg/kg body weight (Group B)
Number of subjects: 22
Study: 6123635

Group type: EXPERIMENTAL
Intervention: Cereal-based electrolyte solution (30 g rice powder per litre)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard sucrose‐electrolyte solution
Number of subjects: 124
Study: 31559916

Group type: EXPERIMENTAL
Intervention: Implicit racial discrimination
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Explicit racial discrimination
Number of subjects: 198

Group type: COMPARATOR
Intervention: No discrimination control
Number of subjects: 198
Study: 28385937

Group type: EXPERIMENTAL
Intervention: Multimodal infiltration with posterior capsular infiltration (PCI)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Multimodal infiltration without posterior capsular infiltration (PCI)
Number of subjects: 86
Study: 24521459

Group type: EXPERIMENTAL
Intervention: Repeated individual dietary counselling by a nutritionist during and after pregnancy
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control group (no dietary counselling)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Repeated individual dietary counselling
Number of subjects: 256
Study: 24273453

Group type: EXPERIMENTAL
Intervention: Nefopam plus Ondansetron (Group O)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Nefopam alone (Group N)
Number of subjects: 230
Study: 21779086

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 5145
Study: 19411363

Group type: EXPERIMENTAL
Intervention: Enhanced relapse prevention training
Number of subjects: 56
Study: 17572321

Group type: EXPERIMENTAL
Intervention: Caudal epidural block (CEB) (n = 12)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Local anesthetic infiltration (LAI) (n = 10)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Caudal epidural block (CEB)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Local anesthetic infiltration (LAI)
Number of subjects: 22
Study: 14961886

Group type: EXPERIMENTAL
Intervention: Outpatient hysteroscopy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Daycase hysteroscopy
Number of subjects: 97
Study: 10961474

Group type: EXPERIMENTAL
Intervention: 150 mg acetylsalicylic acid (ASA)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 9135811

Group type: EXPERIMENTAL
Intervention: Two different target types
Number of subjects: 7
Study: 1544078

Group type: EXPERIMENTAL
Intervention: Physician reminder group
Number of subjects: 5242

Group type: EXPERIMENTAL
Intervention: Telephone reminder group
Number of subjects: 5242

Group type: EXPERIMENTAL
Intervention: Letter reminder group
Number of subjects: 5242

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 5242
Study: 3839446

Group type: EXPERIMENTAL
Intervention: 15 mg ciramadol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 mg ciramadol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60 mg ciramadol
Number of subjects: 0

Group type: COMPARATOR
Intervention: 325 mg aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 650 mg aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linear and curvilinear pain analog intensity scales
Number of subjects: 0
Study: 2885928

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg at night
Number of subjects: 132

Group type: COMPARATOR
Intervention: Ranitidine 300 mg at night
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 132
Study: 29755474

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (SLE-TR, n=9)
Number of subjects: 19
Study: 25796150

Group type: EXPERIMENTAL
Intervention: Huayu Zhitong powder
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional Shangke Jiegu tablets
Number of subjects: 200
Study: 23650000

Group type: EXPERIMENTAL
Intervention: Patients with relapsing-remitting multiple sclerosis (MS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patients with advanced stage MS (duration of 5-6 years)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Female patients with advanced stage MS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (15 individuals)
Number of subjects: 30
Study: 20739691

Group type: EXPERIMENTAL
Intervention: Joint mobilization self‐exercise treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Occlusal splints
Number of subjects: 52
Study: 18259011

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 863

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 863
Study: 16701922

Group type: EXPERIMENTAL
Intervention: Enriched milk (500 cm³ per day) with 5.7 g of oleic acid, 0.2 g of omega-3 fatty acid, 150 µg of folic acid, and 7.5 mg of vitamin E
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (500 cm³ semi-skimmed milk per day)
Number of subjects: 72
Study: 12673463

Group type: EXPERIMENTAL
Intervention: Topical application of pure natural honey (20 ml before, after, and 6 hours post-radiation therapy)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (radiation alone)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Topical application of pure natural honey
Number of subjects: 40
Study: 10718162

Group type: EXPERIMENTAL
Intervention: Initial motivation (CMR scores)
Number of subjects: 0
Study: 9184260

Group type: EXPERIMENTAL
Intervention: M-CSF expression in periprosthetic tissues (interface and pseudocapsule)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Synovial tissue from patients with primary THR for osteoarthritis
Number of subjects: 20
Study: 1603402

Group type: EXPERIMENTAL
Intervention: XYLIHEX
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CHX
Number of subjects: 45

Group type: COMPARATOR
Intervention: F
Number of subjects: 45
Study: 2580172

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg) while fasting
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) after eating
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice a day for 3-12 months) taken 1 h before eating
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice a day for 3-12 months) taken during or immediately after eating
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31775406

Group type: EXPERIMENTAL
Intervention: C-arm guided percutaneous RF ablation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Local intradermal BTX-A injection
Number of subjects: 80
Study: 29049149

Group type: EXPERIMENTAL
Intervention: Modified nasal septal chain suture technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Previous nasal septal chain suture technique
Number of subjects: 40
Study: 26658447

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (>140 mg/dL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normoglycemia (≤140 mg/dL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher glucose levels (per 10 mg/dL increase) in patients with incomplete reperfusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complete reperfusion
Number of subjects: 0
Study: 25398084

Group type: EXPERIMENTAL
Intervention: Personalized DNA-based dietary advice for 12 months
Number of subjects: 138

Group type: COMPARATOR
Intervention: General dietary recommendations with no genetic information for 12 months
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Personalized DNA-based dietary advice for 12 months (for those with risk version of ACE gene)
Number of subjects: 138
Study: 24321171

Group type: EXPERIMENTAL
Intervention: Structured training program based on the mhGAP intervention guide
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 86
Study: 20229136

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard TKA
Number of subjects: 13
Study: 17988643

Group type: EXPERIMENTAL
Intervention: Pentacam (Oculus, Inc, Wetzlar, Germany)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Ultrasound pachymetry
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Difference between Pentacam and ultrasound
Number of subjects: 53
Study: 16644277

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS with low-plasma valproate levels
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS with high-plasma valproate levels
Number of subjects: 15

Group type: COMPARATOR
Intervention: 1 Hz rTMS in healthy subjects
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Correlation between plasma valproate levels and motor threshold changes after 1 Hz rTMS
Number of subjects: 15
Study: 15055412

Group type: EXPERIMENTAL
Intervention: 2 consecutive synthetic polyester fiber (Dacron) swabs
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Single Dacron swab
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tampon
Number of subjects: 103

Group type: COMPARATOR
Intervention: Clinician-directed sampling of the ectocervix and endocervix
Number of subjects: 103